Processa Pharmaceuticals stock is up on Tuesday as PCSA investors react to approval for a Phase 2 clinical trial of NGC-Cap. More
Articles
SWK Stock Earnings: Stanley Black & Decker Beats EPS, Beats Revenue for Q2 2024
SWK stock results show that Stanley Black & Decker beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
EPD Stock Earnings: Enterprise Prods Partners Misses EPS, Misses Revenue for Q2 2024
EPD stock results show that Enterprise Prods Partners missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. More
IT Stock Earnings: Gartner Beats EPS, Beats Revenue for Q2 2024
IT stock results show that Gartner beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
LDOS Stock Earnings: Leidos Holdings Beats EPS, Beats Revenue for Q2 2024
LDOS stock results show that Leidos Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
JBLU Stock Earnings: JetBlue Airways Beats EPS, Beats Revenue for Q2 2024
JBLU stock results show that JetBlue Airways beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
AWI Stock Earnings: Armstrong World Indus Beats EPS, Beats Revenue for Q2 2024
AWI stock results show that Armstrong World Indus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. More
